Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 5, 2012, Pages 1014.e11-1014.e14

  Yu, Jin Tai ^a   Song, Jing Hui ^b   Wang, Nai Dong ^b   Wu, Zhong Chen ^a   Zhang, Qun ^a   Zhang, Na ^a   Zhang, Wei ^a   Xuan, Shi Ying ^a   Tan, Lan ^a  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Alzheimer's disease; Association; Interleukin 33; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CHINESE; CONTROLLED STUDY; FEMALE; GENDER; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTERLEUKIN 33 GENE; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84858341708     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.07.003     Document Type: Article

References (16)

1. Chapuis J., Hot D., Hansmannel F., Kerdraon O., Ferreira S., Hubans C., Maurage C.A., Huot L., Bensemain F., Laumet G., Ayral A.M., Fievet N., Hauw J.J., DeKosky S.T., Lemoine Y., Iwatsubo T., Wavrant-Devrièze F., Dartigues J.F., Tzourio C., Buée L., Pasquier F., Berr C., Mann D., Lendon C., Alpérovitch A., Kamboh M.I., Amouyel P., Lambert J.C. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol. Psychiatry 2009, 14:1004-1016.
2. Di Bona D., Candore G., Franceschi C., Licastro F., Colonna-Romano G., Cammà C., Lio D., Caruso C. Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res. Rev. 2009, 61:60-68.
3. Di Bona D., Plaia A., Vasto S., Cavallone L., Lescai F., Franceschi C., Licastro F., Colonna-Romano G., Lio D., Candore G., Caruso C. Association between the interleukin-1beta polymorphisms and Alzheimer's disease: A systematic review and meta-analysis. Brain Res. Rev. 2008, 59:155-163.
4. Donohoe G.G., Salomäki A., Lehtimäki T., Pulkki K., Kairisto V. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin. Chem. 1999, 45:143-146.
5. Emanuele E., Lista S., Ghidoni R., Binetti G., Cereda C., Benussi L., Maletta R., Bruni A.C., Politi P. Chromosome 9p21.3 genotype is associated with vascular dementia and Alzheimer's disease. Neurobiol. Aging 2009, 10.1016/j.neurobiolaging.2009.07.003.
6. Farrer L.A., Bowirrat A., Friedland R.P., Waraska K., Korczyn A.D., Baldwin C.T. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum. Mol. Genet 2003, 12:415-422.
7. Hamshere M.L., Holmans P.A., Avramopoulos D., Bassett S.S., Blacker D., Bertram L., Wiener H., Rochberg N., Tanzi R.E., Myers A., Wavrant-De Vrièze F., Go R., Fallin D., Lovestone S., Hardy J., Goate A., O'Donovan M., Williams J., Owen M.J. Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease. Hum. Mol. Genet. 2007, 16:2703-2712.
8. Hudson C.A., Christophi G.P., Gruber R.C., Wilmore J.R., Lawrence D.A., Massa P.T. Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 2008, 84:631-643.
9. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
10. Miller A.M., Xu D., Asquith D.L., Denby L., Li Y., Sattar N., Baker A.H., McInnes I.B., Liew F.Y. IL-33 reduces the development of atherosclerosis. J. Exp. Med 2008, 205:339246.
11. Pericak-Vance M.A., Grubber J., Bailey L.R., Hedges D., West S., Santoro L., Kemmerer B., Hall J.L., Saunders A.M., Roses A.D., Small G.W., Scott W.K., Conneally P.M., Vance J.M., Haines J.L. Identification of novel genes in late-onset Alzheimer's disease. Exp. Gerontol 2000, 35:1343-1352.
12. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med 2010, 362:329-344.
13. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
14. Vasto S., Candore G., Listì F., Balistreri C.R., Colonna-Romano G., Malavolta M., Lio D., Nuzzo D., Mocchegiani E., Di Bona D., Caruso C. Inflammation, genes and zinc in Alzheimer's disease. Brain Res. Rev. 2008, 58:96-105.
15. Yu J.T., Tan L., Song J.H., Sun Y.P., Chen W., Miao D., Tian Y. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res. 2009, 1253:169-175.
16. Yu J.T., Yu Y., Zhang W., Wu Z.C., Li Y., Zhang N., Tan L. Single nucleotide polymorphism rs1333049 on chromosome 9p213 is associated with Alzheimer's disease in Han Chinese. Clin. Chim. Acta 2010, 411:1204-1207.